Abstract
The course of uraemia in 47 patients with renal amyloidosis has been studied. The median survival with a S-creatinine of 150 μmol/l was approximately 18 months, but 15% survived for more than 3 years. Deterioration arose often suddenly and was of unclear cause. Approximately 25% of the patients improved for a while and the reason for this temporary improvement is also unclear. The unsteady course during the uraemia period for amyloidosis patients makes prognosis calculations very much less accurate than for patients with cystic kidneys.
Similar content being viewed by others
References
Ogg, C. S., Cameron, J. S., Williams, D. G., Turner, D. R.: Presentation and course of primary amyloidosis of the kidney.Clin. Nephrol., 15, 9 (1981).
Browning, M. J., Banks, R. A., Tribe, C. R., Hollingworth, P., Kingswood, C., Mackenzie, J. C., Bacon, P. A.: Ten years’ experience of an amyloid clinic. A clinicopathological survey.Quart. J. Med. New Series, 54, 215 (1985).
Andersen, S., Lindqvist, B., Nyström, L.: Prognosis curves for patients with polycystic kidney disease.Ann. Clin. Res., 14, 90, (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindqvist, B., Andersen, S., Isacsson, B. et al. The course of renal amyloidosis with uraemia. International Urology and Nephrology 21, 555–559 (1989). https://doi.org/10.1007/BF02549595
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549595